ANI Pharmaceuticals, Inc.
ANIP
$64.58
-$0.90-1.37%
Headlines
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET
4/18/2024
-
Globe Newswire
4/18/2024
-
Zacks Investment Research
4/18/2024
-
Zacks Investment Research
4/18/2024
-
Zolmax
4/18/2024
-
Zolmax
4/17/2024
-
Zacks Investment Research
4/16/2024
-
Zacks Investment Research
4/16/2024
-
Zacks Investment Research
4/16/2024
-
Zacks Investment Research
4/16/2024
-
Zacks Investment Research
4/16/2024
-
Zacks Investment Research
4/16/2024
-
Zacks Investment Research
4/16/2024
-
Zolmax
4/16/2024
-
Ticker Report
4/15/2024
-
Zacks Investment Research
4/15/2024
-
Zacks Investment Research
4/15/2024
-
Zacks Investment Research
4/13/2024
-
Ticker Report
4/12/2024
-
Simply Wall St
4/12/2024
-
Zacks Investment Research
4/11/2024
-
PR Newswire
4/10/2024
-
Zacks Investment Research
4/10/2024
-
Zacks Investment Research
4/10/2024
-
Zacks Investment Research
4/10/2024
-
Zacks Investment Research
Filings
Thursday, February 29, 2024
Sunday, December 31, 2023
Week of May 6 and 10 (est)
Price History
Corporate Info
218 634 3500
210 Main Street West
Baudette, MN 56623
Baudette, MN 56623
Business Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company...
more